PPAC: Inventory of the Management of Acute Community-acquired Pneumonia in the Pneumology Department of the Strasbourg University Hospitals

Sponsor

University Hospital, Strasbourg, France (Other)

Overall Status

Recruiting

CT.gov ID

NCT05661513

Collaborator

(none)

1,000

Enrollment

Location

Anticipated Duration (Months)

33.4

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Acute community-acquired pneumonia (CAP) refers to an acute infection of the lung parenchyma, occurring within the first 48 hours of hospitalization. It is a frequent, serious pathology with a strong economic impact. Viruses (rhinovirus, respiratory syncitial virus, influenza virus for the most common) and Streptococcus pneumoniae are the most frequently encountered pathogens. However, more than half of the PACs have no microbiological documentation. The management of CAPs is based on national and international recommendations. Several studies have shown imperfect compliance by clinicians with recommendations with a prognostic impact.

The various published studies insist on the variability of the incidence, the type of pathogen, the severity and the economic impact, depending on the series. They also insist on the need to know the local epidemiology, in particular microbiological, in order to adapt the recommendations.

Condition or Disease	Intervention/Treatment	Phase
Infection, Lung Parenchyma

Detailed Description

The objective of the study is to determine the epidemiological, clinical, biological and imaging characteristics of people admitted for acute community-acquired pneumonia.

Study Design

Study Type:

Observational

Anticipated Enrollment :

1000 participants

Observational Model:

Case-Only

Time Perspective:

Retrospective

Official Title:

Inventory of the Management of Acute Community-acquired Pneumonia in the Pneumology Department of the Strasbourg University Hospitals

Actual Study Start Date :

Sep 9, 2022

Anticipated Primary Completion Date :

Mar 1, 2025

Anticipated Study Completion Date :

Mar 9, 2025

Outcome Measures

Primary Outcome Measures

Retrospectively determine the epidemiological, clinical, biological and imaging characteristics of people admitted for acute community-acquired pneumonia [Files analysed retrospectively from January 01, 2015 to December 31, 2019 will be examined]
Retrospective analysis of health data from patients' medical records

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years and Older

Sexes Eligible for Study:

All

Inclusion criteria:

Adult subject (≥ 18 years old),
acute community-acquired pneumonia (< 48 hours after admission),
admitted from the Emergency Department, consultation or home.
Subject not objecting to the reuse of their data for scientific research purposes

Exclusion criteria:

Expressed refusal to reuse data for scientific research purposes.
bronchitis, acute nosocomial pneumopathy, secondary infection due to bronchial dilation.